Latvia vs South Sudan: Access to anti-retroviral drugs, male
Latvia
51.0%
in 2024
South Sudan
52.0%
in 2024
Latvia rank
116th
South Sudan rank
113th
Access to anti-retroviral drugs, male over time
- Latvia
- South Sudan
How they compare
South Sudan currently reports 52.0% against 51.0% in Latvia, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Latvia ahead.
Latvia ranks 116th and South Sudan ranks 113th of 141 countries.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.3% | 0.1% | 3.2% | Latvia |
| 2010s | 22.3% | 10.0% | 12.3% | Latvia |
| 2020s | 49.0% | 39.4% | 9.6% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Latvia or South Sudan?
- South Sudan, at 52.0% against 51.0% in Latvia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Latvia and South Sudan?
- 1.0%, with South Sudan ahead.
- How many years of comparable data are there for Latvia and South Sudan?
- 25 years are reported by both, from 2000 to 2024.
- How do Latvia and South Sudan rank globally for access to anti-retroviral drugs, male?
- Latvia ranks 116th and South Sudan ranks 113th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.